PEAK6
DGX icon

PEAK6’s Quest Diagnostics DGX Stock Holding History

PEAK6’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-19,310
Closed -$3.35M – 3080
2025
Q1 		$3.27M Buy
+19,310
New +$3.17M 0.01% 1151

Other funds holding DGX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
EIG
EdgePoint Investment Group Toronto, Ontario, Canada $12.5B AUM 31.7% 1-Year Est. Return

PEAK6's DGX Position: Q2 2025 in Review

PEAK6 sold out of Quest Diagnostics (DGX) in Q2 2025, closing a stake of 19,310 shares — an estimated $3.35M sold.

PEAK6 first reported a position in DGX in Q1 2025 and held it in 1 quarter. The position peaked at $3.27M in Q1 2025. 990 funds tracked by Wall St. Rank hold DGX as of Q2 2025.

  • PEAK6 reported no remaining Quest Diagnostics position as of Q2 2025 after selling out during the quarter.
  • PEAK6 sold 19,310 Quest Diagnostics shares in Q2 2025, an estimated $3.35M.
  • PEAK6 first reported a position in Quest Diagnostics in Q1 2025 and held it in 1 quarter.
  • PEAK6's Quest Diagnostics position peaked at $3.27M in Q1 2025.
  • 990 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2025.

Based on PEAK6's 13F filing for Q2 2025, filed 14 Aug 2025.